Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M802787200 on August 4, 2008

J. Biol. Chem., Vol. 283, Issue 40, 26850-26858, October 3, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/40/26850    most recent
M802787200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, P.-H.
Right arrow Articles by Nagy, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, P.-H.
Right arrow Articles by Nagy, L. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Suppression of Lipopolysaccharide-stimulated Tumor Necrosis Factor-{alpha} Production by Adiponectin Is Mediated by Transcriptional and Post-transcriptional Mechanisms*

Pil-Hoon Park{ddagger}1, Honglian Huang{ddagger}1, Megan R. McMullen{ddagger}1, Palash Mandal{ddagger}, Lei Sun{ddagger}, and Laura E. Nagy{ddagger}§2

From the Departments of {ddagger}Pathobiology and §Gastroenterology, Cleveland Clinic, Cleveland, Ohio 44195

Adiponectin is an adipokine with potent anti-inflammatory properties. Treatment of macrophages with adiponectin results in a suppression of lipopolysaccharide (LPS)-stimulated cytokine production. Here we investigated the transcriptional and post-transcriptional mechanisms by which adiponectin suppresses LPS-stimulated tumor necrosis factor (TNF)-{alpha} production. Treatment of RAW 264.7 macrophages with LPS increased TNF-{alpha} promoter-driven luciferase activity (TNF-{alpha} promoter/Luc activity) by 20-fold over basal. After culture with 1 µg/ml globular adiponectin (gAcrp) for 18 h, TNF-{alpha} promoter/Luc activity was increased even in the absence of LPS; further challenge with LPS only increased TNF-{alpha} promoter/Luc activity by 1.4-fold. Treatment with gAcrp decreased LPS-stimulated ERK1/2 phosphorylation and I{kappa}B degradation and suppressed the ability of LPS to increase the DNA binding activity of Egr-1 and p65. gAcrp also suppressed LPS-mediated stabilization of TNF-{alpha} mRNA. In controls cells, the half-life of TNF-{alpha} mRNA was increased from ~30 min at base line to ~80 min in response to LPS. After treatment with gAcrp for 18 h, LPS failed to increase TNF-{alpha} mRNA stability. This gAcrp-mediated loss of stimulus-induced stabilization of TNF-{alpha} mRNA required the presence of the TNF-{alpha} 3'-untranslated region and was associated with an increase in expression and RNA binding activity of tristetraprolin, an mRNA-binding protein that destabilizes TNF-{alpha} mRNA. In summary, these data characterize the complex transcriptional and post-transcriptional effects of gAcrp on LPS-stimulated TNF-{alpha} expression in macrophages. gAcrp treatment profoundly suppressed the ability of LPS to increase TNF-{alpha} transcription and reduced the stimulus-induced stabilization of TNF-{alpha} mRNA in response to LPS.


Received for publication, April 10, 2008 , and in revised form, July 8, 2008.

* This work was supported, in whole or in part, by National Institutes of Health Grants AA011975 and AA013868 (to L. E. N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Both authors contributed equally to this work.

2 To whom correspondence should be addressed: Cleveland Clinic Foundation, LRI/NE40, 9500 Euclid Ave., Cleveland, OH 44195. Tel.: 216-444-4021; Fax: 216-636-1493; E-mail: laura.nagy{at}case.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
V. Zacharioudaki, A. Androulidaki, A. Arranz, G. Vrentzos, A. N. Margioris, and C. Tsatsanis
Adiponectin Promotes Endotoxin Tolerance in Macrophages by Inducing IRAK-M Expression
J. Immunol., May 15, 2009; 182(10): 6444 - 6451.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Higuchi, K. Ohashi, S. Kihara, K. Walsh, and N. Ouchi
Adiponectin Suppresses Pathological Microvessel Formation in Retina Through Modulation of Tumor Necrosis Factor-{alpha} Expression
Circ. Res., May 8, 2009; 104(9): 1058 - 1065.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
Z. Shen, J. M. Ajmo, C. Q. Rogers, X. Liang, L. Le, M. M. Murr, Y. Peng, and M. You
Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-{alpha} production in cultured macrophage cell lines
Am J Physiol Gastrointest Liver Physiol, May 1, 2009; 296(5): G1047 - G1053.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement